ducovest

HEEM:BATS-iShares Currency Hedged MSCI Emerging Markets ETF (USD)

ETF | Diversified Emerging Mkts |

Last Closing

USD 27.34

Change

+0.07 (+0.26)%

Market Cap

USD 0.38B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks to track the investment results of the MSCI Emerging Markets 100% Hedged to USD Index. The fund generally will invest at least 90% of its assets in the component securities (including indirect investments through the underlying fund) and other instruments of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is an equity benchmark for global emerging markets stock performance with the currency risk inherent in the securities included in the index hedged to the U.S. dollar on a monthly basis.

Currency: USD

Country : USA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Diversified Emerging Mkts

Symbol Name Price(Change) Market Cap
EEMV iShares MSCI Emerging Markets ..

+0.21 (+0.36%)

 USD 3.98B

ETFs Containing HEEM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diversified Emerging Mkts) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.23% 100% F 54% F
Dividend Return 0.74% 50% F 10% F
Total Return 11.97% 100% F 52% F
Trailing 12 Months  
Capital Gain 12.42% 100% F 58% F
Dividend Return 0.75% 50% F 11% F
Total Return 13.17% 100% F 57% F
Trailing 5 Years  
Capital Gain 2.88% 100% F 36% F
Dividend Return 12.75% 100% F 55% F
Total Return 15.63% 100% F 32% F
Average Annual (5 Year Horizon)  
Capital Gain 2.17% 50% F 33% F
Dividend Return 4.04% 100% F 37% F
Total Return 1.87% 100% F 65% D
Risk Return Profile  
Volatility (Standard Deviation) 18.80% 50% F 22% F
Risk Adjusted Return 21.47% 50% F 20% F
Market Capitalization 0.38B 50% F 82% B

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to earnings

The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.